HeartBeam director granted 50,000 RSUs

HeartBeam, Inc. director Richard Ferrari reported an equity award of 50,000 shares of common stock in the form of restricted stock units.

Rhea-AI Filing Summary

HeartBeam, Inc. director Richard Ferrari reported an equity award of 50,000 shares of common stock in the form of restricted stock units. The grant was made on February 9, 2026 and increased his directly held position to 229,136 shares.

According to the award terms, one half of the RSU shares will vest on March 31, 2026, and the remaining half will vest on June 30, 2026, based on a vesting commencement date of January 1, 2026. The RSUs were issued under HeartBeam’s 2022 Equity Incentive Plan and carry no cash exercise price.

Insider Trade Summary

Grant/Award: 50,000 shares

Grant/Award 1 txn

Insider Ferrari Richard

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 229,136 shares (Direct)

Footnotes (1)

1. F1. These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HeartBeam (BEAT) director Richard Ferrari report?

Richard Ferrari reported receiving an award of 50,000 restricted stock units of HeartBeam common stock. The grant was made on February 9, 2026 and increased his directly held position to 229,136 shares following the transaction, reflecting routine equity-based director compensation.

How do the 50,000 HeartBeam RSUs granted to Richard Ferrari vest?

Ferrari’s 50,000 RSUs vest in two equal tranches. One half vests on March 31, 2026, and the remaining half vests on June 30, 2026. Both dates are tied to a vesting commencement date of January 1, 2026 for this special RSU grant.

What type of security was reported in Richard Ferrari’s HeartBeam Form 4?

The Form 4 reports an acquisition of restricted stock units (RSUs) that settle in HeartBeam common stock. These RSUs were granted at a price of $0.00 per share as an equity award, rather than a market purchase, and were issued under the 2022 Equity Incentive Plan.

How many HeartBeam shares does Richard Ferrari own after this RSU grant?

After the reported RSU grant, Richard Ferrari’s directly held position is 229,136 shares of HeartBeam common stock. This figure includes the newly awarded 50,000 restricted stock units, which will convert to shares as they vest on the scheduled 2026 vesting dates.

Under which plan were Richard Ferrari’s HeartBeam RSUs granted?

The 50,000 restricted stock units reported for Richard Ferrari were issued under HeartBeam’s 2022 Equity Incentive Plan. This plan authorizes equity awards such as RSUs for directors and other participants, with these specific RSUs subject to vesting dates in March and June 2026.

Did Richard Ferrari buy or sell HeartBeam shares for cash in this Form 4?

The Form 4 shows an equity award, not a cash transaction. Ferrari received 50,000 restricted stock units at a stated price of $0.00 per share, reflecting a compensation grant rather than an open-market purchase or sale of HeartBeam stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 05:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferrari Richard

(Last) (First) (Middle)

2118 WALSH AVENUE, SUITE 210

(Street)

SANTA CLARA CALIFORNIA 95050

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		50,000	A	$0	229,136	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

	/s/ Richard Ferrari	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)